APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lower Limb Exoskeleton Rehabilitation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lower Limb Exoskeleton Rehabilitation Market Outlook and Growth Opportunities 2026

27 December 2025192 pages

Choose your research edition.

Industry ResearchLower Limb Exoskeleton Rehabilitation Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Lower Limb Exoskeleton Rehabilitation Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Lower Limb Exoskeleton Rehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lower Limb Exoskeleton Rehabilitation Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lower Limb Exoskeleton Rehabilitation Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Lower Limb Exoskeleton Rehabilitation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lower Limb Exoskeleton Rehabilitation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lower Limb Exoskeleton Rehabilitation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lower Limb Exoskeleton Rehabilitation market include Milebot, Hangzhou Taixi Intelligent Technology, Hangzhou Chengtian Technology, Parker Hannifin, Panasonic, Myomo, Marsi Bionics, LockHeed Martin and Lifeward, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lower Limb Exoskeleton Rehabilitation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lower Limb Exoskeleton Rehabilitation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lower Limb Exoskeleton Rehabilitation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lower Limb Exoskeleton Rehabilitation market size, projected growth trends, production technologies, key applications, and end-use industries.

Lower Limb Exoskeleton Rehabilitation Segment by Company

Milebot

Hangzhou Taixi Intelligent Technology

Hangzhou Chengtian Technology

Parker Hannifin

Panasonic

Myomo

Marsi Bionics

LockHeed Martin

Lifeward

Hocoma

Ekso Bionics

Cyberdyne

B-TEMIA Inc.

Bionik Laboratories

Alter G

Lower Limb Exoskeleton Rehabilitation Segment by Type

For Adults

For Children

Lower Limb Exoskeleton Rehabilitation Segment by Application

Rehabilitation Center

Family

Other

Lower Limb Exoskeleton Rehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lower Limb Exoskeleton Rehabilitation status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Lower Limb Exoskeleton Rehabilitation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lower Limb Exoskeleton Rehabilitation significant trends, drivers, influence factors in global and regions.

6. To analyze Lower Limb Exoskeleton Rehabilitation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lower Limb Exoskeleton Rehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lower Limb Exoskeleton Rehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lower Limb Exoskeleton Rehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lower Limb Exoskeleton Rehabilitation market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lower Limb Exoskeleton Rehabilitation industry.

Chapter 3: Detailed analysis of Lower Limb Exoskeleton Rehabilitation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Lower Limb Exoskeleton Rehabilitation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Lower Limb Exoskeleton Rehabilitation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lower Limb Exoskeleton Rehabilitation Industry Trends Table 2. Lower Limb Exoskeleton Rehabilitation Industry Drivers Table 3. Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges Table 4. Lower Limb Exoskeleton Rehabilitation Industry Restraints Table 5. Global Lower Limb Exoskeleton Rehabilitation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lower Limb Exoskeleton Rehabilitation Revenue Share by Company (2021-2026) Table 7. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Company (2021-2026) Table 9. Global Lower Limb Exoskeleton Rehabilitation Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Lower Limb Exoskeleton Rehabilitation Company Ranking, (2024-2026) & (USD Million) Table 11. Global Lower Limb Exoskeleton Rehabilitation Key Company Manufacturing Base & Headquarters Table 12. Global Lower Limb Exoskeleton Rehabilitation Company, Product Type & Application Table 13. Global Lower Limb Exoskeleton Rehabilitation Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Lower Limb Exoskeleton Rehabilitation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of For Adults Table 18. Significant Companies of For Children Table 19. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Type (2021-2026) Table 23. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Type (2027-2032) Table 24. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type (2021-2026) Table 28. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Rehabilitation Center Table 30. Significant Companies of Family Table 31. Significant Companies of Other Table 32. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Application (2021-2026) Table 36. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Application (2027-2032) Table 37. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application (2021-2026) Table 41. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application (2027-2032) Table 42. Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2026) & (K Units) Table 44. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region (2021-2026) Table 45. Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2027-2032) & (K Units) Table 46. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region (2027-2032) Table 47. Global Lower Limb Exoskeleton Rehabilitation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Region (2021-2026) Table 50. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Region (2027-2032) Table 52. Global Lower Limb Exoskeleton Rehabilitation Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Lower Limb Exoskeleton Rehabilitation Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Lower Limb Exoskeleton Rehabilitation Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026) & (K Units) Table 57. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2021-2026) Table 58. Global Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032) & (K Units) Table 59. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Country (2027-2032) Table 60. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Lower Limb Exoskeleton Rehabilitation Sales Value Market Share by Country (2021-2026) Table 62. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Lower Limb Exoskeleton Rehabilitation Sales Value Market Share by Country (2027-2032) Table 64. Milebot Company Information Table 65. Milebot Business Overview Table 66. Milebot Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 68. Milebot Recent Development Table 69. Hangzhou Taixi Intelligent Technology Company Information Table 70. Hangzhou Taixi Intelligent Technology Business Overview Table 71. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 73. Hangzhou Taixi Intelligent Technology Recent Development Table 74. Hangzhou Chengtian Technology Company Information Table 75. Hangzhou Chengtian Technology Business Overview Table 76. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 78. Hangzhou Chengtian Technology Recent Development Table 79. Parker Hannifin Company Information Table 80. Parker Hannifin Business Overview Table 81. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 83. Parker Hannifin Recent Development Table 84. Panasonic Company Information Table 85. Panasonic Business Overview Table 86. Panasonic Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 88. Panasonic Recent Development Table 89. Myomo Company Information Table 90. Myomo Business Overview Table 91. Myomo Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 93. Myomo Recent Development Table 94. Marsi Bionics Company Information Table 95. Marsi Bionics Business Overview Table 96. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 98. Marsi Bionics Recent Development Table 99. LockHeed Martin Company Information Table 100. LockHeed Martin Business Overview Table 101. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 103. LockHeed Martin Recent Development Table 104. Lifeward Company Information Table 105. Lifeward Business Overview Table 106. Lifeward Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 108. Lifeward Recent Development Table 109. Hocoma Company Information Table 110. Hocoma Business Overview Table 111. Hocoma Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 113. Hocoma Recent Development Table 114. Ekso Bionics Company Information Table 115. Ekso Bionics Business Overview Table 116. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 118. Ekso Bionics Recent Development Table 119. Cyberdyne Company Information Table 120. Cyberdyne Business Overview Table 121. Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 123. Cyberdyne Recent Development Table 124. B-TEMIA Inc. Company Information Table 125. B-TEMIA Inc. Business Overview Table 126. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 128. B-TEMIA Inc. Recent Development Table 129. Bionik Laboratories Company Information Table 130. Bionik Laboratories Business Overview Table 131. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 133. Bionik Laboratories Recent Development Table 134. Alter G Company Information Table 135. Alter G Business Overview Table 136. Alter G Lower Limb Exoskeleton Rehabilitation Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio Table 138. Alter G Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Lower Limb Exoskeleton Rehabilitation Distributors List Table 142. Lower Limb Exoskeleton Rehabilitation Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Lower Limb Exoskeleton Rehabilitation Product Image Figure 2. Global Lower Limb Exoskeleton Rehabilitation Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 4. Global Lower Limb Exoskeleton Rehabilitation Sales (2021-2032) & (K Units) Figure 5. Global Lower Limb Exoskeleton Rehabilitation Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Lower Limb Exoskeleton Rehabilitation Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. For Adults Image Figure 10. For Children Image Figure 11. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Type (2021-2032) Figure 14. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type (2021-2032) Figure 17. Rehabilitation Center Image Figure 18. Family Image Figure 19. Other Image Figure 20. Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Application (2021-2032) Figure 23. Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application (2021-2032) Figure 26. Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Lower Limb Exoskeleton Rehabilitation Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Lower Limb Exoskeleton Rehabilitation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 31. North America Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 37. South America Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Lower Limb Exoskeleton Rehabilitation Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Lower Limb Exoskeleton Rehabilitation Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • For Adults
  • For Children
Applications
  • Rehabilitation Center
  • Family
  • Other
Companies covered
  • Milebot
  • Hangzhou Taixi Intelligent Technology
  • Hangzhou Chengtian Technology
  • Parker Hannifin
  • Panasonic
  • Myomo
  • Marsi Bionics
  • LockHeed Martin
  • Lifeward
  • Hocoma
  • Ekso Bionics
  • Cyberdyne
  • B-TEMIA Inc.
  • Bionik Laboratories
  • Alter G

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  4. 1.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales Volume (2021-2032)
  5. 1.2.3 Global Lower Limb Exoskeleton Rehabilitation Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Lower Limb Exoskeleton Rehabilitation Market Dynamics
  1. 2.1 Lower Limb Exoskeleton Rehabilitation Industry Trends
  2. 2.2 Lower Limb Exoskeleton Rehabilitation Industry Drivers
  3. 2.3 Lower Limb Exoskeleton Rehabilitation Industry Opportunities and Challenges
  4. 2.4 Lower Limb Exoskeleton Rehabilitation Industry Restraints
3 Lower Limb Exoskeleton Rehabilitation Market by Company
  1. 3.1 Global Lower Limb Exoskeleton Rehabilitation Company Revenue Ranking in 2025
  2. 3.2 Global Lower Limb Exoskeleton Rehabilitation Revenue by Company (2021-2026)
  3. 3.3 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Company (2021-2026)
  4. 3.4 Global Lower Limb Exoskeleton Rehabilitation Average Price by Company (2021-2026)
  5. 3.5 Global Lower Limb Exoskeleton Rehabilitation Company Ranking (2024-2026)
  6. 3.6 Global Lower Limb Exoskeleton Rehabilitation Company Manufacturing Base and Headquarters
  7. 3.7 Global Lower Limb Exoskeleton Rehabilitation Company Product Type and Application
  8. 3.8 Global Lower Limb Exoskeleton Rehabilitation Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Lower Limb Exoskeleton Rehabilitation Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Lower Limb Exoskeleton Rehabilitation Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Lower Limb Exoskeleton Rehabilitation Market by Type
  1. 4.1 Lower Limb Exoskeleton Rehabilitation Type Introduction
  2. 4.1.1 For Adults
  3. 4.1.2 For Children
  4. 4.2 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type
  5. 4.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type
  9. 4.3.1 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Type (2021-2032)
  11. 4.3.3 Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type (2021-2032)
5 Lower Limb Exoskeleton Rehabilitation Market by Application
  1. 5.1 Lower Limb Exoskeleton Rehabilitation Application Introduction
  2. 5.1.1 Rehabilitation Center
  3. 5.1.2 Family
  4. 5.1.3 Other
  5. 5.2 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application
  6. 5.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Lower Limb Exoskeleton Rehabilitation Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application
  10. 5.3.1 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Application (2021-2032)
  12. 5.3.3 Global Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application (2021-2032)
6 Lower Limb Exoskeleton Rehabilitation Regional Sales and Value Analysis
  1. 6.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2021-2032)
  3. 6.2.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Region: 2021-2026
  4. 6.2.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Region (2027-2032)
  5. 6.3 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region (2021-2032)
  7. 6.4.1 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region: 2021-2026
  8. 6.4.2 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Region (2027-2032)
  9. 6.5 Global Lower Limb Exoskeleton Rehabilitation Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  12. 6.6.2 North America Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  15. 6.7.2 Europe Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  21. 6.9.2 South America Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Lower Limb Exoskeleton Rehabilitation Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Lower Limb Exoskeleton Rehabilitation Sales Value Share by Country, 2025 VS 2032
7 Lower Limb Exoskeleton Rehabilitation Country-level Sales and Value Analysis
  1. 7.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2032)
  4. 7.3.1 Global Lower Limb Exoskeleton Rehabilitation Sales by Country (2021-2026)
  5. 7.3.2 Global Lower Limb Exoskeleton Rehabilitation Sales by Country (2027-2032)
  6. 7.4 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country (2021-2032)
  7. 7.4.1 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country (2021-2026)
  8. 7.4.2 Global Lower Limb Exoskeleton Rehabilitation Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Lower Limb Exoskeleton Rehabilitation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Milebot
  2. 8.1.1 Milebot Company Information
  3. 8.1.2 Milebot Business Overview
  4. 8.1.3 Milebot Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Milebot Lower Limb Exoskeleton Rehabilitation Product Portfolio
  6. 8.1.5 Milebot Recent Developments
  7. 8.2 Hangzhou Taixi Intelligent Technology
  8. 8.2.1 Hangzhou Taixi Intelligent Technology Company Information
  9. 8.2.2 Hangzhou Taixi Intelligent Technology Business Overview
  10. 8.2.3 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Hangzhou Taixi Intelligent Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  12. 8.2.5 Hangzhou Taixi Intelligent Technology Recent Developments
  13. 8.3 Hangzhou Chengtian Technology
  14. 8.3.1 Hangzhou Chengtian Technology Company Information
  15. 8.3.2 Hangzhou Chengtian Technology Business Overview
  16. 8.3.3 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Hangzhou Chengtian Technology Lower Limb Exoskeleton Rehabilitation Product Portfolio
  18. 8.3.5 Hangzhou Chengtian Technology Recent Developments
  19. 8.4 Parker Hannifin
  20. 8.4.1 Parker Hannifin Company Information
  21. 8.4.2 Parker Hannifin Business Overview
  22. 8.4.3 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Parker Hannifin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  24. 8.4.5 Parker Hannifin Recent Developments
  25. 8.5 Panasonic
  26. 8.5.1 Panasonic Company Information
  27. 8.5.2 Panasonic Business Overview
  28. 8.5.3 Panasonic Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Panasonic Lower Limb Exoskeleton Rehabilitation Product Portfolio
  30. 8.5.5 Panasonic Recent Developments
  31. 8.6 Myomo
  32. 8.6.1 Myomo Company Information
  33. 8.6.2 Myomo Business Overview
  34. 8.6.3 Myomo Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Myomo Lower Limb Exoskeleton Rehabilitation Product Portfolio
  36. 8.6.5 Myomo Recent Developments
  37. 8.7 Marsi Bionics
  38. 8.7.1 Marsi Bionics Company Information
  39. 8.7.2 Marsi Bionics Business Overview
  40. 8.7.3 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Marsi Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  42. 8.7.5 Marsi Bionics Recent Developments
  43. 8.8 LockHeed Martin
  44. 8.8.1 LockHeed Martin Company Information
  45. 8.8.2 LockHeed Martin Business Overview
  46. 8.8.3 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LockHeed Martin Lower Limb Exoskeleton Rehabilitation Product Portfolio
  48. 8.8.5 LockHeed Martin Recent Developments
  49. 8.9 Lifeward
  50. 8.9.1 Lifeward Company Information
  51. 8.9.2 Lifeward Business Overview
  52. 8.9.3 Lifeward Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lifeward Lower Limb Exoskeleton Rehabilitation Product Portfolio
  54. 8.9.5 Lifeward Recent Developments
  55. 8.10 Hocoma
  56. 8.10.1 Hocoma Company Information
  57. 8.10.2 Hocoma Business Overview
  58. 8.10.3 Hocoma Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hocoma Lower Limb Exoskeleton Rehabilitation Product Portfolio
  60. 8.10.5 Hocoma Recent Developments
  61. 8.11 Ekso Bionics
  62. 8.11.1 Ekso Bionics Company Information
  63. 8.11.2 Ekso Bionics Business Overview
  64. 8.11.3 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Ekso Bionics Lower Limb Exoskeleton Rehabilitation Product Portfolio
  66. 8.11.5 Ekso Bionics Recent Developments
  67. 8.12 Cyberdyne
  68. 8.12.1 Cyberdyne Company Information
  69. 8.12.2 Cyberdyne Business Overview
  70. 8.12.3 Cyberdyne Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cyberdyne Lower Limb Exoskeleton Rehabilitation Product Portfolio
  72. 8.12.5 Cyberdyne Recent Developments
  73. 8.13 B-TEMIA Inc.
  74. 8.13.1 B-TEMIA Inc. Company Information
  75. 8.13.2 B-TEMIA Inc. Business Overview
  76. 8.13.3 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 B-TEMIA Inc. Lower Limb Exoskeleton Rehabilitation Product Portfolio
  78. 8.13.5 B-TEMIA Inc. Recent Developments
  79. 8.14 Bionik Laboratories
  80. 8.14.1 Bionik Laboratories Company Information
  81. 8.14.2 Bionik Laboratories Business Overview
  82. 8.14.3 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bionik Laboratories Lower Limb Exoskeleton Rehabilitation Product Portfolio
  84. 8.14.5 Bionik Laboratories Recent Developments
  85. 8.15 Alter G
  86. 8.15.1 Alter G Company Information
  87. 8.15.2 Alter G Business Overview
  88. 8.15.3 Alter G Lower Limb Exoskeleton Rehabilitation Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Alter G Lower Limb Exoskeleton Rehabilitation Product Portfolio
  90. 8.15.5 Alter G Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lower Limb Exoskeleton Rehabilitation Value Chain Analysis
  2. 9.1.1 Lower Limb Exoskeleton Rehabilitation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lower Limb Exoskeleton Rehabilitation Sales Mode & Process
  6. 9.2 Lower Limb Exoskeleton Rehabilitation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lower Limb Exoskeleton Rehabilitation Distributors
  9. 9.2.3 Lower Limb Exoskeleton Rehabilitation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst